Reckitt Benckiser Group PLC Director/PDMR Shareholding (4428R)
February 28 2019 - 6:16AM
UK Regulatory
TIDMRB.
RNS Number : 4428R
Reckitt Benckiser Group PLC
28 February 2019
28 February 2019
RECKITT BENCKISER GROUP PLC
DIRECTOR/PDMR SHAREHOLDINGS
Reckitt Benckiser Group plc (the "Company" or "RB") announces
the following change in the interests of a Director in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
The Company was notified on 27 February 2019 that Andrew
Bonfield, Independent Non-Executive Director, purchased a total of
80 Shares on 27 February 2019 at GBP57.60 per share.
This was in relation to his 2018 remuneration. The remuneration
of RB's Non-Executive Directors includes fees which are to be used
in the purchase of Shares. Approximately 18% of the Non-Executive
Directors' base fee (net) is invested in Shares which they are
expected to retain for the duration of their tenure. The percentage
of Andrew Bonfield's fees applied in this way were pro-rated based
on his appointment to the Board on 1 July 2018.
Following this transaction, Mr Bonfield has a beneficial holding
of 80 Shares in the Company, representing 0.00001% of the total
voting rights of the Company.
The following notification is made in accordance with the
requirements of the EU Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Andrew Bonfield
----------------------------------------- ----------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------- ----------------------------------------
b) Initial notification/ Initial notification
Amendment
----------------------------------------- ----------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer
or auction monitor
-----------------------------------------------------------------------------------
a) Name Reckitt Benckiser Group plc
----------------------------------------- ----------------------------------------
b) LEI 5493003JFSMOJG48V108
----------------------------------------- ----------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions
have been
conducted
-----------------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary shares of 10p each in Reckitt
type of instrument Benckiser Group plc
Identification code GB00B24CGK77
----------------------------------------- ----------------------------------------
b) Nature of the transaction Purchase of shares as part of
requirement for percentage of base fee
to invested in shares
in relation to 2018 fees (following
applicable withholdings in respect of
any tax liability)
(pro-rated based on 18% for NED)
----------------------------------------- ----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP 57.60 80
--------------
----------------------------------------- ----------------------------------------
d) Aggregated information n/a
* Aggregated volume
* Price
----------------------------------------- ----------------------------------------
e) Date of the transaction 2019-02-27
----------------------------------------- ----------------------------------------
f) Place of the transaction London Stock Exchange, Main Market -
XLON
----------------------------------------- ----------------------------------------
For further Information:
Christine Logan
Deputy Company Secretary
Tel +44 (0) 1753 217 800
Richard Joyce
SVP, Investor Relations
Tel. +44 (0)1753 217 800
Reckitt Benckiser Group plc's LEI code is
5493003JFSMOJG48V108
About RB:
RB* is the global leading consumer health, hygiene and home
company. Driven by a purpose of providing innovative solutions for
healthier lives and happier homes, RB has operations in over 60
countries. From the foundations of wellness and infant nutrition,
to the fundamentals of a hygienic home, its global brands help
people live healthier, happier lives.
RB has world leading Powerbrands which include household names
such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex,
Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang,
Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
RB's unique culture is at the heart of its success. Its drive to
achieve, passion to outperform and commitment to quality and
scientific excellence is manifested in the work of over 40,000
employees worldwide.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of
companies
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBBGDDXBDBGCI
(END) Dow Jones Newswires
February 28, 2019 06:16 ET (11:16 GMT)
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From Apr 2023 to Apr 2024